News Center
Details
Miao Jianmin Visits Renfu Pharmaceutical
Release time:
2025-08-25 11:46
Source:
From August 5 to 6, Miao Jianmin, Chairman of China Merchants Group, visited the headquarters of Renfu Pharmaceutical and Yichang Renfu for research and investigation. Zhang Junli, Assistant to the General Manager and Secretary of the Board of Directors of China Merchants Group, as well as Director of the Group Office, participated in the visit.
During his visit to the headquarters of Renfu Pharmaceutical, Miao Jianmin toured the exhibition hall and gained a detailed understanding of the company’s development journey and its cultural construction. He pointed out that Renfu Pharmaceutical is an outstanding company that stays closely attuned to the market, drives growth through innovation, and excels at seizing opportunities. The company boasts a professional team of cadres and employees who are bold in innovation, skilled in management, ready to take on tough challenges, and capable of achieving victory. Since joining the China Merchants Group family, Renfu Pharmaceutical has access to even richer resources, greater development opportunities, and an even brighter future outlook. China Merchants Group will transform Renfu Pharmaceutical into the Group’s core platform for life sciences and a unified platform for the development of the biopharmaceutical industry, comprehensively boosting Renfu Pharmaceutical’s strength, quality, and scale. With the full support of China Merchants Group and the concerted efforts of the new leadership team and all cadres and employees, Renfu Pharmaceutical is bound to radiate new vitality and dynamism.
During his visit to Yichang Renfu, Miao Jianmin toured the company’s exhibition hall, the small-volume injection workshop, and the Pharmaceutical Research Institute, and then held a symposium for in-depth exchanges. He pointed out that Renfu Pharmaceutical should carefully plan its “15th Five-Year” blueprint, firmly adhering to the four guiding principles: “quality is life, innovation is fundamental, internationalization is the future, and talent is the guarantee.” It should also make good use of the China Merchants Group’s platform advantages to achieve win-win development through collaborative partnerships. As a core subsidiary of Renfu Pharmaceutical, Yichang Renfu must not only uphold its inherent strengths, deepen its expertise in niche markets, and strengthen technological innovation, but also leverage its own R&D resource advantages to cultivate new growth areas and expand its scope for development.
During the research visit, Miao Jianmin and his delegation toured the Hubei Jiufengshan Laboratory and Heyuan Bio, both located in the East Lake High-tech Zone in Wuhan, to gain insights into innovative practices aimed at deepening reform of the science and technology system and building new types of R&D institutions. They expressed hope that Zhaoshang Chuangke and Renfu Pharmaceutical would strengthen their study and借鉴 (learning from and drawing on) these practices, and actively strive to become sources of original technological innovation.
Deng Weidong, General Manager of Zhaoshang Chuangke and Chairman of Renfu Pharmaceutical; Liu Zhenhua, Director of the Strategic Development Department/Department of Technological Innovation at China Merchants Group; Nie Liming, Director of the Industrial Development Department/Department of Business Coordination at China Merchants Group; as well as relevant officials from the Office of China Merchants Group, the Human Resources Department, Zhaoshang Chuangke, Renfu Pharmaceutical, and the Wuhan and Yichang branches of China Merchants Bank, attended the research visit.
Trending News
Corporate culture
Make drug launches safer and faster, and ensure the tree of life remains evergreen.
Learn moreContact Us
Business customer service
-
Telephone：:+86-027-86506632
Human Resources Department
Address: No.98 shendun 2nd Road, Donghu New Technology Development Zone, Wuhan
Official wechat
Copyright: Wuhan humanwell likang pharmaceutical co.,ltd